Glycosaminoglycans (GAGs) are measured in urine to screen for mucopolysaccharidoses. Other assay procedures are only qualitative (spot tests), can give false-negative results (spot tests, turbidity tests), or are relatively laborious (uronic acid-carbazole test). The present spectrophotometric procedure, based on the color reaction with dimethylmethylene blue (0MB), can be performed directly on untimed urine samples without prior precipitation. Reference values were age dependent. We tested urines of 27 patients with various mucopolysaccharidoses and compared results by three other procedures (cetylpyridinium chloride turbidity tests at pH 4.8 and at pH 7.0, and the uronic acid-carbazole test). In the DMB assay, GAGs were increased in 26 of the 27 patients. The exception was a Morquio A patient, whose activity of the defective enzyme was higher than in classical Morquio patients. Uronic acid, measured in precipitated GAG by the carbazole test, was increased in 23 of the 25 patients so tested. In the turbidity test at pH 7.0, values were increased in 24 of the 27 patients. In contrast, with the citrate-buffered (pH 4.8) turbidity measurement, GAG content was increased in only 19 of the 27 patients. This rapid and easy 0MB method is a reliable screening procedure for mucopolysaccharidoses and compares well with procedures used hitherto.
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In mucopolysaccharidoses, one of the lysosomal enzymes involved in the degradation of glycosaminoglycans (GAGs) is deficient.3 At least 11 different exo-enzymes (mainly glycosidases and sulfatases) are involved in the complete degradation of the carbohydrate structures into their monomolecular constituents. Deficiency of one of these enzymes results in accumulation of GAGs in cells, and as a consequence in urine; the resulting syndrome depends on which enzyme is deficient. Measurement of glycosaminoglycan content in urine is therefore generally used as a screening procedure for mucopolysaccharidoses. Several assay systems have been developed in the past:
The spot tests (1, 2) . These are quick and simple but not quantitative and, because GAG content in urine is related to age, quantitative measurement is more reliable. De-
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pending on the sensitivity of the test and type of mucopolysaccharidosis involved, either false-positive or falsenegative results may be obtained (3) .
Turbidity tests (4) (5) (6) . The measurements obtained are based on the interaction of GAGs with cationic detergents or albumin. The tests are quantitative, but their sensitivity depends on the type of GAG that is accumulating. For certain types of mucopolysaccharidoses (e.g., Sanfihippo and Morquio) false-negative results may be obtained (6) .
The uronic acid-carbazole test (7, 8 
CPC.

Materials and Methods
Materials
Chondroitin-4-sulfate, heparan sulfate, cetylpyridinium chloride, and cetyltrimethylammonium bromide were from Sigma Chemical Company, St. Louis, MO. 1,9-Dimethylmethylene blue chloride was a product of Serva Fembiochemica GmbH, Heidelberg, F.R.G. For the automated analyses we used a Cobas Bio centrifugal analyzer (Hoffmann-La Roche & Co. AG., Basel, Switzerland). Turbidity was measured with a Hyland Laser Nephelometer PDQ (Travenol, Brussels, Belgium).
Urines were stored at -20 #{176}C; no preservative was added. Pennock (5, 6) . Using this buffer, we found relatively low values for some patients. Better results were obtained at higher pH. CPC turbidity measurements were therefore made at two different pHs: pH 4.8 (citrate buffered) and pH 7.0 (Tris buffered).
Methods
Dimethylmethylene
Urine samples were diluted fivefold in citrate buffer (0. 
Results
Dimethylmethylene Blue Assay
In the manual DMB assay (250 L of sample or standard solution added to 2.50 mL of DMB solution), heparan sulfate gave a linear calibration curve for concentrations between 1 and 70 pg/mL. After linear-regression analysis the following relationship was found between the GAG concentration (x) in p.g/mL and the measured absorbance at 520 nm (y) for the manual assay procedure: y = 0.00106 + 0.00442x (r = 0.999, standard error of the estimate = 0.00154).
Heparan sulfate (from bovine kidney) was used as the standard because the color was not stable when we tried other glycosaminoglycans of tissue origin such as dermatan sulfate (from porcine skin) and chondroitin sulfate (from whale and shark cartilage). In urine samples (patients and controls), however, the color of the DMB-glycosaminoglycan complex was stable for at least 20 mm.
In the automated analysis, readings were made lOs after mixing sample and reagent. Correlation coefficients were 0.999 for each of the calibration curves of the three series. The within-run CV for the automated procedure was 1.8%. A group of 83 normal urines was tested with the DMB assay and the CPC-Tris turbidity assay. Good correlation (r = 0.928) was found between results by these two procedures. The following relationship was found between GAG concentration measured by the CPC-Tris procedure and the GAG by the DMB procedure (both in pg/mL): [DMBI = 0.265 + 0.993[CPC-Trisl. The intercept does not deviate significantly from zero, and the slope does not deviate significantly from 1.
Glycosaminoglycans in Urines from Normal Persons
To establish reference values for the DMB assay, the uronic acid.-carbazole assay and the CPC assays at pH 4.8 and 7.0, we measured GAG concentrations in a series of untimed urine specimens from controls. In Figure 1 , GAG content is given as a function of age for each of the four assay procedures. GAG content is expressed as milligrams per millimole of creatinine or as micromoles of uronic acid per millimole of creatinine. These normal subjects were grouped by age. The change in GAG content as a function of age is greatest in young age groups. In those older than 21 years, GAG content is nearly constant. Therefore groups were selected as indicated in Table 1 , and for each of these the averages and standard deviations were determined. Values measured for normal persons as a function of age were also analyzed by linear regression. GAG content and age correlated well after logarithmic transformation for the DMB assay, the uronic acid-carbazole test, and the CPCTris assay.
Patients
We studied urine specimens from 27 mucopolysaccharidosis patients (diagnosed on the basis of clinical symptoms and low enzyme activity: five Hunter, two Hurler, one Maroteaux-Lamy, six Morquio A, five Scheie, four Sanfilippo A, and four Sanfilippo B), measuring GAG content by the DMB and the CPC (pH 7.0 and 4.8) turbidity assays. Of these, only 25 urines were tested by the carbazole test because only a limited amount of urine was available from two patients (Hurler 1 and Scheie 3 in Table 2 ). Figure 1 shows values measured for patients, together with values for normal urines as a function of age. Table 2 shows whether the patients' values were increased with respect to the established normal values for each of the four assay procedures (i.e., higher than the average value plus two times the standard deviation for the corresponding age group).
We subjected glycosaminoglycans precipitated from Table 2 urines of patients (except for one patient, Hurler 1 in Table   2 , too little material) and 20 controls to one-dimensional electrophoresis, to determine their composition. In 26 of the 27 patients, abnormal patterns were found that accorded with the type of mucopolysaccharidosis.
In one patient (Morquio 3 in Table 2 ) a normal pattern was found, and the GAG content in this urine was normal by all the four assay methods.
In this patient, the activity of the defective enzyme (23% residual activity) was higher than in classical Morquio A patients (<7% residual activity). (12) , and in purification procedures (13) . Use of basic metachromatic dyes in screening for mucopolysaccharidoses has been well described. Panin et al. (14) measured urinary glycosaminoglycans in 24-h urine specimens in an assay based on DMB, but they first precipitated glycosaminoglycans with cetylpyridinium chloride. They found a good correlation with the uronic acid-carbazole test. For the five Morquio patients they tested, values were more increased than with the carbazole test. Coppa et al. (15) tested the same procedure on 44 patients, using 24-h urines, and compared it with the carbazole test. All patients showed a urinary GAG excretion well exceeding the normal reference interval. Especially for Morquio patients, better results were obtained with the DMB assay. Gold (16) described an assay for measuring glycosaminoglycans directly in urines by use of Alcian Blue. The disadvantage of this method is the instability of the Alcian Blue reagent, which must be prepared just before use. The assay was not tested on patients' urines.
In our method, glycosaminoglycans can be measured in small volumes of urine without prior precipitation. Thus the assay is faster than methods used hitherto for GAG determination.
It can be easily automated, and no GAG material is lost because of prepurification procedures.
In addition, our assay is done on untimed urine portions, more conveniently collected than 24-h urines. As can be concluded from the pattern of reference values in Figure 1 , interferences by other substances are negligible and establishment of suitable and useful reference values is facilitated. The assay is not hampered by instability of reagents or by insoluble complexes formed during the assay. In the determination of glycosaminoglycans with DMB the solubifity of the colored complex can be a problem (1 7) , especially with chondroitin and dermat.an sulfate. For this reason commercial chondroitin sulfate and dermatan sulfate isolated from tissues could not be used as standards. Heparan sulfate, however, formed stable soluble complexes, probably because of its lower molecular mass. GAGS in urines from normal persons and mucopolysaccharidosis patients gave complexes that remained soluble during the assay procedure. Apparently the composition of these urinary glycosaminoglycans differs from that of those prepared from tissues. Reference values expressed as described above take into account urine concentration, and untimed urine specimens can be used for screening. As expected, this ratio is dependent on age, and for each of the various age categories we established reference values (Table 1) .
While this paper was in preparation, Whitley et al. (10)  published a study concerning a diagnostic test for muco- polysaccharidoses based on the same procedure as described here. Using a DMB solution comparable in composition with ours, they also found linear calibration curves and, like us, used this assay for direct measurement of GAGS in urine. Their conclusion that the direct DMB assay is a simple, rapid method with precisely quantitative results, circumventing the problems of existing methodologies, is in agreement with our results discussed here. Their paper gave results for four patients, three Hurlers and one With the DMB assay, in 26 of the 27 mucopolysaccharidosis patients the GAG/creatinine ratio was increased (Table 2) , which was better than with the other methods we tested. The patient with a normal GAG content with the DMB method was a woman diagnosed as Morquio A on the basis of clinical symptoms and low enzyme activity. The residual activity of the enzyme measured in leukocytes (23%) was higher than in classical Morquio patients (<7%). The composition of GAGS in the urine of this patient was within normal limits. Apparently the level of storage of GAGS in this case is too low to cause an increased excretion in urine. Patients with Morquio syndrome show a progressive decrease in keratan sulfate excretion when they grow older (18, 19) . In addition, patients with a mild form of Morquio disease type A excrete less keratan sulfate (18) . In this case, excretion may have become normal because of the age of this patient (20 years) and the relatively high residual enzyme activity.
Results of the uromc acid-carbazole test correlated well (r = 0.978) with those by the DMB assay with respect to values for patients. Especially for Sanfihippo patients, values measured with both these methods were more increased than those determined by the turbidity measurement procedures ( Figure 1 , Table 2 ). Uronic acid was increased in 23 of the 25 patients tested ( In the turbidity measurement assays some Scheie, Sanfflippo, and Morquio patients gave normal values. These assays are based on the formation of insoluble complexes with the cationic detergent CPC. Endoglycosidase activities in tissues can degrade (e.g.) heparan sulfate to compounds with lower molecular masses than other GAGS that are stored in mucopolysaccharidoses. Owing to the difference in solubility between the complexes with low-molecular-mass GAGS (Mr <3000) and those with higher-molecular-mass components (20, 21) , the turbidity measurement urines was increased only in 19 of our 27 patients. For the turbidity measurement procedures, results were better when the assays were done in a Ths-buffered system at neutral pH (7.0). At this pH, values were increased in 24 of our 27 patients. From the data in Table 1 for each patient, the standard deviation score (22) , also called the Z-score, can be calculated. For this, the observed patient value minus the average value for the corresponding age group (Table 1) was divided by the standard deviation for that group. The higher the standard deviation score, the better can patients be discriminated from normal. In Table  3 , for each group of patients (Hunter, Morquio, etc.) the #{149} Range in standardd eviation score.
averages and ranges for the standard deviation scores are given for all four assay procedures. (The Morquio A patient with normal GAG content and normal GAG composition was excluded from these calculations.) Scores obtained with the DMB procedure were equal to or higher than the scores obtained with the other assay procedures for almost all types of mucopolysaccharidoses. For Morquio patients the average standard deviation score was 11 for the DMB method and 12 for the CPC-Tris procedure. For Sanfilippo A patients these values were 22 for the DMB method and 24 for the carbazol test. These are minor differences especially when the range in the values is taken into consideration.
We conclude that the DMB assay as described here is a reliable screening procedure for all types of mucopolysaccharidoses. It competes well with procedures used hitherto. The assay can be automated and performed directly on as little as 100 tL of untimed urine specimen. This assay is faster and easier to perform than the comparison methods.
